Literature DB >> 21627017

Significance of magnetic resonance imaging in differential diagnosis of nontraumatic brachial plexopathy.

Stojan Perić1, Slobodan Lavrnić, Ivana Basta, Dusan Damjanović, Tatjana Stosić-Opinćal, Dragana Lavrnić.   

Abstract

BACKGROUND/AIM: Nontraumatic brachial plexopathies may be caused by primary or secondary tumors, radiation or inflammation. The aim of this study was to present the significance of MRI in revealing the cause of nontraumatic brachial plexopathy.
METHODS: A two-year retrospective study included 22 patients with nontraumatic brachial plexopathy. In all the patients typical clinical findings were confirmed by upper limb neurophysiological studies. In all of them MRI of brachial plexus was performed by 1.5 T scanner in T1 and T1 FS sequence with and without contrast, as well as in T2 and T2 FS sequences.
RESULTS: Seven (32%) patients had brachial plexopathy with signs of inflammatory process, 5 (23%) patients had secondary tumors, in 4 (18%) patients multifocal motor neuropathy was established and in the same number (18%) of the patients postradiation fibrosis was found. Two patients (9%) had primary neurogenic tumors.
CONCLUSION: According to the results of this study MRI is a method which may determine localization and cause of brachial plexopathy. MRI can detect focal nerve lesions when other methods fail to find them. Thus, MRI has a direct impact on further diagnostic and therapeutical procedures.

Entities:  

Mesh:

Year:  2011        PMID: 21627017     DOI: 10.2298/vsp1104327p

Source DB:  PubMed          Journal:  Vojnosanit Pregl        ISSN: 0042-8450            Impact factor:   0.168


  2 in total

Review 1.  High-resolution 3T MR neurography of the brachial plexus and its branches, with emphasis on 3D imaging.

Authors:  A Chhabra; G K Thawait; T Soldatos; R S Thakkar; F Del Grande; M Chalian; J A Carrino
Journal:  AJNR Am J Neuroradiol       Date:  2012-09-13       Impact factor: 3.825

2.  Clinical Utility of (18)F-FDG PET/CT in brachial plexopathy secondary to metastatic breast cancer.

Authors:  Piyush Chandra; Nilendu Purandare; Archi Agrawal; Sneha Shah; Venkatesh Rangarajan
Journal:  Indian J Nucl Med       Date:  2016 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.